Purple Biotech Ltd (PPBT) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2022 and annually, average high and low, overall ranking from Dec 31 2024 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Purple Biotech Ltd  (NASDAQ: PPBT)

Purple Biotech Ltd's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Purple Biotech Ltd in the fourth quarter 2024?
Purple Biotech Ltd achieved a return on average equity (ROE) of 26.86 % in its fourth quarter 2024, this is above PPBT's average return on equity of -29.61%.
Purple Biotech Ltd shareholder's equity over the 12 months ending in its fourth quarter 2024 are valued at $27 million

ROE fell compared to the third quarter 2024, despite the net income growth of % from the third quarter 2024.

Within the Major Pharmaceutical Preparations industry 388 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2024 from to 580.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Equity Change -70.65 % -4.04 % -30.12 % -30.12 % -
Y / Y Net Income Change -66.55 % - - - 17.83 %
Net Income (TTM) in Millions 7 22 22 22 22
Return On Equity (TTM) 26.86 % 66.12 % 65.43 % 59.12 % 53.93 %
PPBT's Total Ranking # 580 # # # #
Equity (TTM) in Millions 10 33 33 33 33
Seq. Equity Change -70.65 % 0 % 0 % 0 % -4.04 %
Seq. Net Income Change - - - - -

Back to PPBT Management Effectiveness >> PPBT's 5 Years Annual ROE >> Compare PPBT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 389
Sector # 819
Overall # 580

Return On Equity Statistics
High Average Low
50.61 %
-29.61 %
-274.27 %
(Dec 31 2018)   (Dec 31 2025)





PPBT Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 10 33 34 47 65
Y / Y Equity Change -70.65 % -4.04 % -27.18 % -27.66 % -18.36 %
Net Income in Millions -26 -7 -20 -22 18
Y / Y Net Income Change - - - - -34.22 %
Return On Equity -274.27 % -22.12 % -58.25 % -46.2 % 28.37 %

Back to PPBT Management Effectiveness >> PPBT's 5 Years Annual ROE >> Compare PPBT ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PPBT's' Return on Equity at Yahoo Finance
PPBT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PPBT's Competitors
Subscribers only: Roe for Purple Biotech Ltd's Suppliers
Subscribers only: Return On Equity for PPBT's Customers




Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector ROE
Addex Therapeutics Ltd  72.91 %
Abbvie Inc   70.54 %
Novo Nordisk A  70.38 %
Nrc Health  69.30 %
Amgen Inc   67.18 %
Dariohealth Corp   61.81 %
Agios Pharmaceuticals Inc   58.94 %
Idexx Laboratories Inc  55.82 %
Exelixis Inc   54.88 %
Promis Neurosciences inc   51.55 %
Medpace Holdings Inc   51.48 %
Zoetis Inc   49.70 %
Pharmacyte Biotech Inc   49.09 %
Edwards Lifesciences Corporation  48.53 %
Protagonist Therapeutics inc   47.67 %
Sbc Medical Group Holdings Incorporated  47.47 %
Carlisle Companies Incorporated  47.32 %
Puma Biotechnology Inc   46.10 %
Galmed Pharmaceuticals Ltd   45.94 %
Waters Corporation  41.68 %
Insulet Corporation  40.62 %
Acadia Pharmaceuticals Inc   39.54 %
Merck and Co Inc   39.16 %
Semler Scientific inc   34.63 %
Medinotec Inc   34.27 %
Entrada Therapeutics Inc   34.08 %
Siga Technologies Inc  33.00 %
Abbott Laboratories  32.19 %
Hims and Hers Health Inc   31.06 %
Kewaunee Scientific Corporation  30.86 %

Date modified: 2026-09-02T18:44:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.